Besides IFN-γ, another cytokine, IFN-α, an important signaling protein to recruit myeloid cells during innate immunity, has also been used as adjunctive therapy in TB, but its potential for treatment remains uncertain. The gene discussed is IFNA1; the disease is tuberculosis.